Trademark: 87116365
Word
DRIVE
Status
Dead
Status Code
710
Status Date
Tuesday, May 28, 2024
Serial Number
87116365
Registration Number
5336382
Registration Date
Tuesday, November 14, 2017
Mark Type
4
Filing Date
Tuesday, July 26, 2016
Published for Opposition
Tuesday, December 27, 2016
Cancellation Date
Tuesday, May 28, 2024

Trademark Owner History
Durata Therapeutics Holding C.V. - Original Registrant

Classifications
44 Providing a registry of patients for whom the antibiotic dalbavancin has been prescribed which is used for gathering medical-related real world safety, effectiveness, and usage data; none of the above relating to or in the field of cancer treatment, cancer research, genomic research or gene sequencing

Trademark Events
Nov 9, 2016
Examiners Amendment E-Mailed
Nov 9, 2016
Notification Of Examiners Amendment E-Mailed
Nov 9, 2016
Examiners Amendment -Written
Jul 29, 2016
New Application Entered
Jul 29, 2016
New Application Office Supplied Data Entered
Nov 5, 2016
Assigned To Examiner
Nov 9, 2016
Examiner's Amendment Entered
Mar 31, 2017
Assigned To Petition Staff
Nov 16, 2016
Approved For Pub - Principal Register
Dec 7, 2016
Notification Of Notice Of Publication E-Mailed
Dec 27, 2016
Published For Opposition
Dec 27, 2016
Official Gazette Publication Confirmation E-Mailed
Jan 23, 2017
Extension Of Time To Oppose Received
Mar 15, 2017
Teas Post Publication Amendment Received
Jul 10, 2017
Use Amendment Filed
Aug 4, 2017
Case Assigned To Intent To Use Paralegal
Aug 25, 2017
Su - Non-Final Action - Written
Aug 25, 2017
Non-Final Action E-Mailed
Aug 25, 2017
Notification Of Non-Final Action E-Mailed
Aug 29, 2017
Teas Response To Office Action Received
Sep 10, 2017
Assigned To Lie
Apr 1, 2017
Changes/Corrections After Pub Approval Entered
May 7, 2017
Extension Of Time To Oppose Process - Terminated
Jun 21, 2017
Noa E-Mailed - Sou Required From Applicant
Jul 10, 2017
Teas Statement Of Use Received
Aug 5, 2017
Statement Of Use Processing Complete
Oct 5, 2017
Su - Non-Final Action - Written
Oct 13, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 14, 2017
Registered-Principal Register
Nov 14, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 28, 2024
Cancelled Sec. 8 (6-Yr)
Oct 12, 2017
Allowed Principal Register - Sou Accepted
Sep 11, 2017
Correspondence Received In Law Office
Sep 11, 2017
Teas/Email Correspondence Entered
Oct 5, 2017
Non-Final Action E-Mailed
Oct 5, 2017
Notification Of Non-Final Action E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24